UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical relevance of circulating tumor DNA using amplicon-based deep sequencing panel in colorectal cancer patients with liver metastasis

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii181

2018

Volltextzugriff (PDF)

A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii158

2018

Volltextzugriff (PDF)

BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer

ESMO Gastrointestinal Oncology, 2024-06, Vol.4, p.100066, Article 100066

2024

Volltextzugriff (PDF)

Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis

ESMO Gastrointestinal Oncology, 2024-09, Vol.5, p.100072, Article 100072

2024

Volltextzugriff (PDF)

p16 and PD-L1 expression in locoregional squamous cell carcinoma of the anal canal: A single center retrospective analysis in Japan

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii170

2018

Volltextzugriff (PDF)

First‐line mFOLFOX6 for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake

Annals of oncology, 2018-06, Vol.29, p.v23-v23

2018

Volltextzugriff (PDF)

Is the PEG-G-CSF useful as the prevention for the severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab?

Annals of oncology, 2018-06, Vol.29, p.v62-v62

2018

Volltextzugriff (PDF)

Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract

Annals of oncology, 2018-06, Vol.29, p.v29-v29

2018

Volltextzugriff (PDF)

Real-world outcomes of trifluridine/tipiracil for heavily pretreated patients with advanced gastric cancer

ESMO Gastrointestinal Oncology, 2024-03, Vol.3, p.100046, Article 100046

2024

Volltextzugriff (PDF)

Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

ESMO open, 2023-08, Vol.8 (4), p.101582-101582, Article 101582

2023

Volltextzugriff (PDF)

Severe ischemic colitis after treatment of bile-duct cancer using gemcitabine and cisplatin

Japanese journal of clinical oncology, 2015-04, Vol.45 (4), p.402-403

2015

Volltextzugriff (PDF)

Development of an orthosis for walking assistance using pneumatic artificial muscle: A quantitative assessment of the effect of assistance

2013 IEEE 13th International Conference on Rehabilitation Robotics (ICORR), 2013-06, Vol.2013, p.1-6

2013

Volltextzugriff (PDF)

A retrospective analysis of the association between perioperative carcinoembryonic antigen level and prognosis in stage III colorectal cancer

Annals of oncology, 2018-11, Vol.29, p.ix42-ix42

2018

Volltextzugriff (PDF)

A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care

ESMO open, 2021-10, Vol.6 (5), p.100234-100234, Article 100234

2021

Volltextzugriff (PDF)

P-052Phase II study of biweekly cetuximab and irinotecan as third-line therapy in patients with pre-treated KRAS exon2 wild-type metastatic colorectal cancer

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii16-ii16

2016

Volltextzugriff (PDF)

Status and future prospect of 48Ca double beta decay search in CANDLES

Journal of physics. Conference series, 2016-06, Vol.718 (6), p.62026

2016

Volltextzugriff (PDF)

The CANDLES experiment for the study of Ca-48 double beta decay

Nuclear and particle physics proceedings, 2016-04, Vol.273-275, p.2633-2635

2016

Volltextzugriff (PDF)

348P Prediction of sensitivity to anti-EGFR inhibitors in salvage-line treatment for metastatic colorectal cancer using a modified MethyLight assay

Annals of oncology, 2022-09, Vol.33, p.S695

2022

Volltextzugriff (PDF)

P-33 Prognostic impact of single organ pulmonary metastasis in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors as second-line chemotherapy

Annals of oncology, 2022-06, Vol.33, p.S258-S259

2022

Volltextzugriff (PDF)

P-34 Does the chemotherapeutic efficacy of trifluridine/tipiracil plus bevacizumab change depend on pre-treatment vascular endothelial growth factor inhibitors?

Annals of oncology, 2022-06, Vol.33, p.S259

2022

Volltextzugriff (PDF)

1465P Potential impact of APC mutation on survival via immune evasion through WNT signaling activation in HER2-positive gastric cancer treated with trastuzumab (tmab), nivolumab (nivo), and chemotherapy

Annals of oncology, 2024-09, Vol.35, p.S907-S907

2024

Volltextzugriff (PDF)

1442P Correlation between intratumor HER2 heterogeneity and circulating tumor DNA in HER2 positive advanced gastric cancer: A phase Ib trial of HER2 and PD-1 dual targeted therapy (Ni-High) substudy

Annals of oncology, 2024-09, Vol.35, p.S897-S897

2024

Volltextzugriff (PDF)

P-118 Clinical significance of primary tumor sites and epithelial tumor markers in patients with unresectable/recurrent gastrointestinal neuroendocrine carcinoma treated with combined chemotherapy with irinotecan and cisplatin

Annals of oncology, 2023-06, Vol.34, p.S56-S56

2023

Volltextzugriff (PDF)

567P Interim endoscopic restaging after induction chemotherapy to predict complete response and survival after total neoadjuvant therapy in low rectal cancer: Ad-hoc analysis of the IMPACT trial

Annals of oncology, 2024-09, Vol.35, p.S463-S463

2024

Volltextzugriff (PDF)

1566P Clinical relevance of circulating tumor DNA in HER2 -positive advanced gastric cancer: Results from phase Ib trial of HER2 and PD-1 dual targeted therapy (Ni-High)

Annals of oncology, 2023-10, Vol.34, p.S875-S876

2023

Volltextzugriff (PDF)

1 – 25 von 559

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(383)
Mit Volltextzugriff
(467)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(523)
Japanisch
(64)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(321)
Life Sciences & Biomedicine
(217)
Animals
(105)
Biological And Medical Sciences
(94)
Humans
(91)
Technology
(84)
Male
(72)
Fundamental And Applied Biological Sciences. Psychology
(55)
Female
(53)
Rats
(53)
Biochemistry & Molecular Biology
(49)
Medical Sciences
(41)
Physical Sciences
(38)
Mice
(33)
Chemistry
(29)
Cell Biology
(28)
Exact Sciences And Technology
(28)
Adult
(27)
Molecular Sequence Data
(26)
Neurosciences & Neurology
(25)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Clinical relevance of circulating tumor DNA using amplicon-based deep sequencing panel in colorectal cancer patients with liver metastasis

A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study

BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer

Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis

p16 and PD-L1 expression in locoregional squamous cell carcinoma of the anal canal: A single center retrospective analysis in Japan

First‐line mFOLFOX6 for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake

Is the PEG-G-CSF useful as the prevention for the severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab?

Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract

Real-world outcomes of trifluridine/tipiracil for heavily pretreated patients with advanced gastric cancer

Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma

Severe ischemic colitis after treatment of bile-duct cancer using gemcitabine and cisplatin

Development of an orthosis for walking assistance using pneumatic artificial muscle: A quantitative assessment of the effect of assistance

A retrospective analysis of the association between perioperative carcinoembryonic antigen level and prognosis in stage III colorectal cancer

A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care

P-052Phase II study of biweekly cetuximab and irinotecan as third-line therapy in patients with pre-treated KRAS exon2 wild-type metastatic colorectal cancer

Status and future prospect of 48Ca double beta decay search in CANDLES

The CANDLES experiment for the study of Ca-48 double beta decay

348P Prediction of sensitivity to anti-EGFR inhibitors in salvage-line treatment for metastatic colorectal cancer using a modified MethyLight assay

P-33 Prognostic impact of single organ pulmonary metastasis in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors as second-line chemotherapy

P-34 Does the chemotherapeutic efficacy of trifluridine/tipiracil plus bevacizumab change depend on pre-treatment vascular endothelial growth factor inhibitors?

1465P Potential impact of APC mutation on survival via immune evasion through WNT signaling activation in HER2-positive gastric cancer treated with trastuzumab (tmab), nivolumab (nivo), and chemotherapy

1442P Correlation between intratumor HER2 heterogeneity and circulating tumor DNA in HER2 positive advanced gastric cancer: A phase Ib trial of HER2 and PD-1 dual targeted therapy (Ni-High) substudy

P-118 Clinical significance of primary tumor sites and epithelial tumor markers in patients with unresectable/recurrent gastrointestinal neuroendocrine carcinoma treated with combined chemotherapy with irinotecan and cisplatin

567P Interim endoscopic restaging after induction chemotherapy to predict complete response and survival after total neoadjuvant therapy in low rectal cancer: Ad-hoc analysis of the IMPACT trial

1566P Clinical relevance of circulating tumor DNA in HER2 -positive advanced gastric cancer: Results from phase Ib trial of HER2 and PD-1 dual targeted therapy (Ni-High)

Suchergebnisse filtern